Examples
|
| Tofranil | imipramine hydrochloride | |
| Norpramin | desipramine | |
Tricyclic antidepressants (TCAs) come in tablet form and
are usually taken in the evening. But they may be taken midafternoon and at
bedtime, which can help prevent accidental wetting that occurs early in the
night.
How It Works
The exact way that TCAs help reduce
bed-wetting is not known. They may affect the muscles
of the
bladder, or they may have some effect on the hormone
that causes the kidneys to release urine (antidiuretic hormone). They may work by causing the child to sleep more
lightly.
Why It Is Used
TCAs may help decrease bed-wetting
for short periods of time for children 6 years and older. These medicines most
often are used with another form of treatment such as praise and encouragement
(motivational therapy).
- TCAs are most helpful for children who have
normal-sized bladders. They also work well for children who had periods of
bladder control before starting treatment.
- TCAs work best for older
children and children who do not have frequent daytime accidental
wetting.
How Well It Works
Both imipramine and desipramine
have been shown to reduce the number of wet nights and help children have 14
dry nights in a row.1
About half of the
children who take imipramine for bed-wetting are able to control bed-wetting,
at least for a short time. After they stop taking the medicine, about 30 out of
100 of those children will wet the bed again.2
Side Effects
Side effects that may occur with TCAs
include:
- Constipation.
- Dry
mouth.
- Nervousness.
- Anxiety.
- Difficulty
sleeping (insomnia).
- Mood or personality changes.
Other side effects that are less common include:
- Headaches.
- Abdominal
pain.
- Decreased appetite.
- Blurred
vision.
- Uncontrollable crying.
If a child takes a larger dose (accidental overdose), death
could occur. A child who has taken an overdose of a TCA may have:
- A very fast
heartbeat.
- Seizures.
- Coma (cannot be
awakened).
- Low blood pressure (hypotension).
See Drug Reference for a full list of side effects. (Drug
Reference is not available in all systems.)
What To Think About
Imipramine is being used less
often because other medicines have been more effective and have fewer risks.
Because there have been rare reports of deaths associated with imipramine use,
the benefits of using it need to outweigh the risks.
TCAs usually
are given for 3 to 4 months and then tapered off over 3 to 4 weeks until they
are stopped altogether. They also may be used for shorter lengths of time such
as for camps, overnight outings, or vacation. Ask the doctor if your child
should try the medicine for 6 weeks before the outing. Then you can tell if it
will work when your child needs it to.
TCAs should not be used to
treat children younger than 6 years of age.
TCAs have not been
shown to be helpful in stopping bed-wetting in older teens or children who have
small bladders.
TCAs are not recommended for long-term treatment
of accidental wetting. Some children actually get worse the longer they take
TCAs. The reason for this is not known.
If TCAs are stopped
suddenly, without tapering off the dosage, accidental wetting usually starts
again.
The U.S.
Food and Drug Administration (FDA) has issued an
advisory on this kind of medicine and the risk of
suicide. The FDA does not recommend that people stop using these medicines, but
to watch for
warning signs of suicide in those using them. This is
especially important at the beginning of treatment or when doses are changed.
Complete the new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.
References
Citations
Kiddoo D (2007). Nocturnal enuresis, search date March
2007. Online version of BMJ Clinical Evidence. Also
available online: http://www.clinicalevidence.com.
Boris NW, Dalton R (2007). Enuresis (bed-wetting)
section of Vegetative disorders. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., pp. 113-115.
Philadelphia: Saunders Elsevier.
Credits
| Author | Debby Golonka, MPH |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Tracy Landauer |
| Primary Medical Reviewer | Michael J. Sexton, MD - Pediatrics |
| Specialist Medical Reviewer | Thomas Emmett Francoeur, MDCM, CSPQ, FRCPC - Pediatrics |
| Last Updated | November 12, 2008 |
Kiddoo D (2007). Nocturnal enuresis, search date March
2007. Online version of BMJ Clinical Evidence. Also
available online: http://www.clinicalevidence.com.
Boris NW, Dalton R (2007). Enuresis (bed-wetting)
section of Vegetative disorders. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., pp. 113-115.
Philadelphia: Saunders Elsevier.